• Title of article

    Halogenated inhalational anaesthetics

  • Author/Authors

    Florian M. Reichle، نويسنده , , Peter F. Conzen، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2003
  • Pages
    18
  • From page
    29
  • To page
    46
  • Abstract
    The halogenated inhalational anaesthetics halothane, enflurane, isoflurane and desflurane can produce metabolic hepatocellular injury in humans to a variable extent. During metabolism of these anaesthetics, tissue acetylation occurs due to the formation of reactive intermediates. Proteins modified by acetylation may constitute neo-antigens with a potential for triggering an antibody-mediated immune response. The likelihood of suffering post-operative immune hepatitis depends on the amount of the anaesthetic metabolized and is thereby considerably less with enflurane, isoflurane or desflurane compared with halothane. Plasma inorganic fluoride concentrations are regularly increased after sevoflurane. Elevated inorganic fluoride concentrations have been associated with nephrotoxicity following methoxyflurane anaesthesiabut not after sevoflurane. Another source of concern is the products of degradation from reactions with carbon dioxide absorbents. Most important is compound A, which has been shown to exhibit nephrotoxicity in rodents. However, no significant changes in renal function parameters have been reported in surgical patients.
  • Keywords
    Nephrotoxicity , hepatotoxicity , Fluoride , halothane , isoflurane , Sevoflurane , volatile anaesthetic drug , enflurane , desflurane , hepatic injury , halothane hepatitis , compound A
  • Journal title
    Best Practice and Research Clinical Anaesthesiology
  • Serial Year
    2003
  • Journal title
    Best Practice and Research Clinical Anaesthesiology
  • Record number

    464939